Transforming cancer treatment by enhancing immunotherapy
We develop innovative cancer therapies to induce tumor necrosis and enhance antitumor immunity, offering cancer patients the hope of longer, better lives.
Our innovative platform radically remodels the tumor immune microenvironment of solid cancers, unlocking the ability to successfully treat cancer patients who respond poorly to existing immunotherapies.
Our innovative approaches aim to enhance immune checkpoint inhibitors (ICIs) and prolong the lives of patients with solid tumor cancers that have metastasized to the liver.
Every day, we are exploring new ways to improve the lives of patients with solid tumor cancers. Join our growing team of experts.
For questions regarding partnership opportunities, investor relations, media coverage, or other inquiries, please reach out to us.